Who are CellFE's investors?

CellFE's investors include Dynamk Capital, Cota Capital, Creative Destruction Lab (CDL), Elm Street Ventures, Embark Ventures, GreatPoint Ventures, M Ventures, Khosla Ventures.

How much funding has CellFE raised?

CellFE has disclosed $25.6M raised across 2 rounds.

Where is CellFE headquartered?

CellFE is headquartered in Atlanta, US.

CellFE

Atlanta, US · Founded 2018 · 20 employees on LinkedIn · 8 known investors

Find your way into CellFE

Paths you didn't know you had: your email and LinkedIn already hold routes to the CellFE team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams. The company's platform enables more efficient and accessible production of cell therapies for treatment applications.

Biotech Deep Tech Hardware Medical Devices

Founders & leadership

CellFE was founded in 2018 by Alla Zamarayeva, Todd Sulchek, PhD, Alex Alexeev, PhD, Todd Sulchek, and Alex Alexeev.

Alla ZamarayevaCEO & Co-founder

Todd Sulchek, PhDCSO & Co-founder

Alex Alexeev, PhDCo-founder

Todd Sulchek CSO & Co-founderTodd Sulchek is a Professor of Mechanical Engineering at Georgia Tech with faculty appointments in Bioengineering and Biomedical Engineering. He previously worked as a Postdoctoral Researcher and Staff Scientist at Lawrence Livermore National Laboratory and earned his PhD in Applied Physics from Stanford University.

Alex AlexeevCo-founder

Investors · 8

Dynamk Capital✓ confirmed by CellFENew York

How we know: Dynamk Capital's portfolio page · the company's own site · a partner's Signal profile · funding news · cellfebiotech.com · Not right? Tell us

Cota Capitallisted by Cota CapitalSan Francisco

How we know: Cota Capital's portfolio page · a partner's Signal profile · funding news · cellfebiotech.com · Not right? Tell us

Creative Destruction Lab (CDL)listed by Creative Destruction Lab (CDL)Toronto · $50K – $250K

Elm Street Ventureslisted by Elm Street VenturesNew Haven · $250K – $1M

How we know: Elm Street Ventures's portfolio page · Not right? Tell us

Embark Ventureslisted by Embark VenturesLos Angeles

How we know: Embark Ventures's portfolio page · funding news · cellfebiotech.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

GreatPoint Ventureslisted by GreatPoint VenturesSan Francisco · $250K – $20M

How we know: GreatPoint Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

M Ventureslisted by M VenturesAmsterdam · $10.8M

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Khosla VenturesreportedMenlo Park · $100K – $20M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$25.6M disclosed across 2 rounds · 2020–2023

$22MSeries ASep 2023 · 3 sources
Source ↗
$3.6MSeries SeedJan 2020 · 2 sources
Cota Capital (lead), Dynamk Capital (lead), Embark Ventures
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Endpoints News: CellFE raises $22M Series A to advance a new cell therapy manufacturing idea | CellFEcellfebiotech.com · Sep 2023

CellFE secures $22 million in Series A financing to advance microfluidics-based cellular engineering platform | CellFEcellfebiotech.com · Sep 2023

CellFE Closes Series Seed Funding Round | CellFEcellfebiotech.com · Jan 2020

Frequently asked questions

What does CellFE do?: CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams. The company's platform enables more efficient and accessible production of cell therapies for treatment applications.
Who founded CellFE?: CellFE was founded by Alla Zamarayeva, Todd Sulchek, PhD, Alex Alexeev, PhD, Todd Sulchek, Alex Alexeev in 2018.
Who are CellFE's investors?: CellFE's investors include Dynamk Capital, Cota Capital, Creative Destruction Lab (CDL), Elm Street Ventures, Embark Ventures, GreatPoint Ventures, M Ventures, Khosla Ventures.
How much funding has CellFE raised?: CellFE has disclosed $25.6M raised across 2 rounds.
Where is CellFE headquartered?: CellFE is headquartered in Atlanta, US.